NEW YORK ( TheStreet) -- CHANGE IN RATINGSAltera ( ALTR) upgraded at Morgan Stanley from Underweight to Equal-weight. Demand is increasing for programmable logic devices. Advanced Micro ( AMD) upgraded at FBR from Market Perform to Outperform. Company can gain market share in the second half of the year. $12 price target. Bed Bath & Beyond ( BBBY) rated new Neutral at UBS. $58 price target. Comp sales and market share gains are likely to decelerate. Conagra Foods ( CAG) upgraded at Barclays from Equal-weight to Overweight, Barclays Capital said. $30 price target. Company is exploring new ways to boost its earnings growth. Catalyst Health ( CHSI) rated new Buy at Citigroup. $74 price target. Company is leveraged to increased demand for customized PBM's. Energen ( EGN) rated new Buy at Keybanc. $75 price target. Company is leveraged to continued growth in the Permian basin. East West Bancorp ( EWBC) upgraded at Morgan Stanley from Underweight to Equal-weight. $25 price target. Company can post above-average loan growth. Finisar ( FNSR) downgraded at Credit Suisse from Outperform to Neutral. $16 price target. Estimates also cut, as fundamentals have likely not yet bottomed. Finisar estimates, target cut at Citigroup. FNSR estimates were lowered through 2013. Company reduced its guidance and continues to face inventory problems. Hold rating and new $16.50 price target. General Mills ( GIS) downgraded at Goldman from Buy to Neutral. $42 price target. Domestic volume and market share are likely to remain weak. Intel ( INTC) downgraded at FBR from Outperform to Market Perform. Valuation call. Korn/Ferry ( KFY) downgraded at Baird from Outperform to Neutral, Robert Baird said. $25 price target. Valuation call, as the company could face increased macro growth risks. Life Time Fitness ( LTM) rated new Neutral at UBS. Valuation call, based on a $37 price target. MGM Resorts ( MGM) rated new Outperform at FBR Capital Markets. $17 price target. Las Vegas demand should improve, with more convention traffic. Office Depot ( ODP) rated new Sell at UBS. $3 price target. Company has its own problems and could be squeezed by slower economic growth. Regions Financial ( RF) downgraded at BofA/Merrill from Buy to Neutral. $6.50 price target. Estimates also cut, given the weaker economic environment. Staples ( SPLS) rated new Buy at UBS. $19 price target. Company should continue to generate solid free cash flow. Xilinx ( XLNX) rated new Equal-weight at Morgan Stanley. Company should begin to see improving demand. End of report.